4//SEC Filing
Jordt Raymond M 4
Accession 0001104659-24-007862
CIK 0001326190other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:32 PM ET
Size
8.5 KB
Accession
0001104659-24-007862
Insider Transaction Report
Form 4
Jordt Raymond M
Chief Business Officer
Transactions
- Award
Stock Options (option to buy)
2024-01-25+163,200→ 163,200 totalExercise: $9.28Exp: 2034-01-25→ Common Stock, par value $0.0001 (163,200 underlying) - Award
Restricted Stock Units
2024-01-25+58,400→ 58,400 total→ Common Stock, par value $0.0001 (58,400 underlying)
Footnotes (3)
- [F1]Twenty-five percent of the shares underlying the option become vested and exercisable on January 25, 2025 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 25, 2025, subject to the reporting person's continued service through the applicable vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F3]The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001960780
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 6:32 PM ET
- Size
- 8.5 KB